AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells. [electronic resource]
Producer: 20190708Description: 3803-3808 p. digitalISSN:- 1791-7530
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Drug Synergism
- Female
- Humans
- Imidazoles -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Pyridines -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- STAT3 Transcription Factor
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Axl Receptor Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.